Showing results (161-170 of 350) with videos related to
Sort By:
Pageof 35
Brain Research|September 18, 1995
MK-801 reverses effects of chronic levodopa on D1 and D2 dopamine agonist-induced rotational behaviorR C Boldry, S M Papa, A M Kask, et al.Psychopharmacology|January 1, 1996
Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviorsC Marin, T M Engber, P Chaudhuri, et al.Neurology|September 1, 1983
Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's diseaseR Durso, C A Tamminga, A Denaro, et al.European Journal of Pharmacology|July 9, 1987
Central cholecystokinin octapeptide reduces glucose utilization in subcortical but not cortical rat brainC A Tamminga, K Tanimoto, S Kuo, et al.Brain Research|August 26, 1996
Effect of long-term haloperidol treatment on striatal neuropeptides: relation to stereotyped behaviorC Marin, T M Engber, M Bonastre, et al.Brain Research|January 15, 1993
NBQX inhibits AMPA-induced locomotion after injection into the nucleus accumbensR C Boldry, M D Kelland, T M Engber, et al.Neurology|April 13, 2000
AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeysS Konitsiotis, P J Blanchet, L Verhagen, et al.Brain Research|April 16, 1984
The ventral surface of the medulla in the rat: pharmacologic and autoradiographic localization of GABA-induced cardiovascular effectsJ R Keeler, C W Shults, T N Chase, et al.Journal of Neural Transmission|January 1, 1985
EMD 23,448: effects of a putative dopamine autoreceptor agonist in choreaR P Newman, C A Tamminga, T N Chase, et al.Neuroscience Letters|November 11, 1988
[3H]MK-801 binding in Alzheimer's diseaseM M Mouradian, P C Contreras, J B Monahan, et al.Pageof 35